Literature DB >> 2117509

Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis.

N J McHugh1, I E James, K Fairburn, P J Maddison.   

Abstract

High levels of IgG antibodies to the multi-enzyme complex bovine pyruvate dehydrogenase (PDHC) were detected by a sensitive ELISA in all patients with histologically proven primary biliary cirrhosis (PBC), in a minority of patients with systemic sclerosis without overt PBC or with chronic liver diseases of another cause and in no rheumatoid arthritis or normal controls. Most (15/21) but not all of these positive patients recognized a 70-kD (E2) component of PDHC on immunoblotting. Additional recognition of a centromere-associated 140-kD polypeptide was associated with the presence of scleroderma-like features (Raynaud's phenomenon and sclerodactyly) in PBC, further emphasizing the serological and clinical overlap between these two conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117509      PMCID: PMC1535039          DOI: 10.1111/j.1365-2249.1990.tb03325.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis.

Authors:  M E Pearson; J C Huff; R C Giorno; S Panicheewa; H N Claman; J C Steigerwald
Journal:  Arthritis Rheum       Date:  1988-05

2.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.

Authors:  N J McHugh; I E James; P J Maddison
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

4.  A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.

Authors:  L J McNeilage; S Whittingham; N McHugh; A J Barnett
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

5.  Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis.

Authors:  F Alderuccio; B H Toh; A J Barnett; J S Pedersen
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

6.  Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens.

Authors:  I H Frazer; I R Mackay; T W Jordan; S Whittingham; S Marzuki
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen.

Authors:  D R Fregeau; P S Leung; R L Coppel; L J McNeilage; T A Medsger; M E Gershwin
Journal:  Arthritis Rheum       Date:  1988-03

8.  Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens.

Authors:  S J Yeaman; S P Fussey; D J Danner; O F James; D J Mutimer; M F Bassendine
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

9.  Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis.

Authors:  M E Gershwin; I R Mackay; A Sturgess; R L Coppel
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

10.  Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.

Authors:  G Ballardini; R Mirakian; F B Bianchi; E Pisi; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

View more
  7 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  [Laboratory diagnostics for systemic sclerosis].

Authors:  R Mierau; A Roers; E Genth
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

3.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies.

Authors:  C C Bunn; M McMorrow
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly.

Authors:  K Miyachi; Y Hirano; T Horigome; T Mimori; H Miyakawa; Y Onozuka; M Shibata; M Hirakata; A Suwa; H Hosaka; S Matsushima; T Komatsu; H Matsushima; R W Hankins; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

6.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

7.  Characterisation of anticytoplasmic antibodies and their clinical associations.

Authors:  W H Koh; J Dunphy; J Whyte; J Dixey; N J McHugh
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.